**What Is Known**Obesity is associated with dyslipidaemia.In Mexico, 35% of adolescents are overweight or obese, and this figure has increased by about 5% since 2006.The 2011 Expert Panel on Integrated Guidelines for Cardiovascular Risk Reduction has endorsed universal lipid screening of children and adolescents to identify dyslipidaemias at early age.**What Is New**Half of the adolescents living in the State of Nuevo León, Mexico have at least 1 abnormal lipid concentration.Low high-density lipoprotein-cholesterol level is the most prevalent dyslipidaemia among Northern Mexican adolescents.Body mass index and abdominal obesity were associated with the prevalence of at least 1 abnormal lipid level.

Dyslipidaemias are abnormal amounts of lipid and/or lipoprotein in the blood that may be related to other diseases, with obesity being the most common, which is typically associated with a combined dyslipidaemia pattern with mild elevation in total cholesterol (TChol) and low-density lipoprotein cholesterol (LDL-chol), moderate to severe elevation in triglycerides (TG), and low high-density lipoprotein cholesterol (HDL-chol) ([@R1]--[@R3]). In Mexico, 35% of adolescents are overweight or obese according to the National Health and Nutrition Survey of Mexico (ENSANUT-2012), and this figure has increased by about 5% since 2006 ([@R4]).

The 2011 Expert Panel on Integrated Guidelines for Cardiovascular Risk Reduction on lipid screening in childhood and adolescence ([@R5]) has endorsed universal screening of all children and adolescents to identify dyslipidaemias at an early age. This recommendation is different from other guidelines ([@R6]--[@R8]), in which screening children older than 2 years is recommended if they have cardiovascular risk factors, have a family history of premature cardiovascular disease (CVD) or dyslipidaemia, are overweight or obese, have other elements of insulin resistance syndrome, or have no available family history. Significant evidence, however, exist that using family history of premature CVD or of cholesterol disorders as the primary factor in determining lipid screening for children misses approximately 30% to 60% of children with dyslipidaemias, in whom accurate and reliable measures of family history are not available ([@R5]). Moreover, several studies have shown that in ∼50% of children with high lipid and lipoprotein levels, abnormal levels will persist over time ([@R9]--[@R12]). Children\'s adverse serum lipid levels predict dyslipidaemia in adulthood and adverse levels of non--HDL-chol also are related to non--lipid cardiovascular risk factors in adulthood ([@R13]).

In the present study we aimed to assess the serum lipid profile, the prevalence of dyslipidaemia, and associated risk factors among North Mexican adolescent population.

METHODS
=======

Study Design, Sample Selection, Recruitment, and Approval
---------------------------------------------------------

The present study was a population-based cross-sectional nutritional survey part of the State Survey of Nutrition and Health--Nuevo León, Mexico, 2011/2012 (EESN-NL 2011/2012), designed by the National Institute of Statistics and Geography (INEGI) to obtain information on the health and nutritional status of the state population (n = 4,653,458; 84.5% residing within the Monterrey Metropolitan area; 94% occupying urban areas). The state was divided into 4 geographical regions (percentage of urban vs rural population): northern (66.1% vs 33.9%), central (72.9% vs 27.1%), southern (15.3% vs 84.7%), and the metropolitan area (89.8% vs 10.2%); globally: 61.0% versus 39.0% ([@R14],[@R15]). For the entire survey, a target of 1059 households per region was assessed using the household as the sampling unit and an average of 2 interviews per household; however, for biochemical measurements a sample size of 640 households was considered sufficient to detect risk factors with 95% confidence and a precision rate of 10% and a nonresponse rate of 40%. In the present study, inclusion criteria were to be an inhabitant censused in the State of Nuevo León and provided fasting blood sample. The analysis was also limited to 11- to 16-year-old adolescent participants who provided a fasting blood test (n = 351; 49.0% girls). Two participants in the same age group living in the same household were not selected. Missing data for lipid profile were found in 6 subjects. Moreover, anthropometric measurements (weight and height) were not available in 43 participants. Pregnant girls (n = 7) or breastfeeding girls (n = 2) were also excluded leaving an analysis sample of 293 (47.8% girls). The study was conducted according to the guidelines laid down in the Declaration of Helsinki, and all procedures involving human subjects were approved by the Scientific Technical Committee of the Public Health and Nutrition Faculty at the Autonomous University of Nuevo, León. Informed written consent was obtained from all subjects and also from the next of kin, carers, or guardians of the minors involved in the study.

Anthropometric Measurements
---------------------------

Height was measured to the nearest millimetre using a mobile stadiometer (SECA 213, Birmingham, UK), with the subject\'s head in the Frankfurt plane. Body weight was determined to the nearest 100 g using a digital scale (Seca 813, Hamburg, Germany). Waist circumference (WC) was measured to the nearest 0.1 cm using a nonstretch measuring tape (Gulik, Lafayette Instrument Co, Lafayette, IN). Height and weight measures were used to calculate body mass index (BMI; kg/m^2^) and WC and height were used to calculate waist-to-height ratio (WHtR).

Overweight and Obesity Definition
---------------------------------

Overweight and obesity were determined based on age- and sex-specific BMI cut-offs developed and proposed for international comparisons by Cole et al ([@R16]), also recommended for use by the International Obesity Task Force.

Abdominal Obesity Definition
----------------------------

A WHtR cut-off of 0.5 was used to define abdominal obesity for both boys and girls ([@R17]).

Biochemical Measurements
------------------------

Venous blood samples were obtained from the antecubital vein in suitable vacutainers after a 12-hour overnight fast. Serum TG, TChol, HDL-chol, and LDL-chol were determined using the Cobas 6000 analyser series (F. Hoffmann-La Roche Ltd, Basel, Switzerland), by "Dr. Bernardo Sepúlveda" laboratory at the Metropolitan Hospital under the Ministry of Health of Nuevo León, Mexico. Non--HDL-chol was calculated as TChol minus HDL-chol.

Definitions for Adverse Serum Lipid Levels and Dyslipidaemia
------------------------------------------------------------

According to the 2011 Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents ([@R5]), serum lipid levels were categorized into 3 subgroups (acceptable, borderline, or high) as follows: TChol (mg/dL): acceptable \<170, borderline 170--199, high ≥200; LDL-chol (mg/dL): acceptable \<110, borderline 110--129, high ≥130; non--HDL-chol (mg/dL): acceptable \<120, borderline 120--144, high ≥145; HDL-chol (mg/dL): acceptable \>45, borderline 40--45, low \<40; TG (mg/dL): acceptable \<90, borderline 90--129, high ≥130.

Dyslipidaemia was defined as the presence of 1 or more of the following conditions: TChol ≥200 mg/dL, LDL-chol ≥130 mg/dL, non--HDL-chol ≥145 mg/dL, HDL-chol \<40 mg/dL, TG ≥130 mg/dL ([@R15]).

Statistical Analysis
--------------------

Analyses were performed with the SPSS statistical software package version 21.0 (SPSS Inc., Chicago, IL). Level of significance for acceptance was *P* \< 0.05. Significant differences in prevalence were calculated by means of *χ*^2^ test. Differences between group means were tested by Mann-Whitney *U* test. Univariate binary logistic regression analyses were used to assess the association between age group, sex, and anthropometric indicators (independent variables) and dyslipidaemia (dependent variable).

RESULTS
=======

Table [1](#T1){ref-type="table"} shows the lipid serum and lipoprotein levels of the participants. There were no significant differences in lipid serum levels between sex and age groups (except for TG levels in boys).

###### 

Serum lipids concentrations among adolescents^∗^

                         All            11--13                 14--16                                                                      
  ---------------------- -------------- ---------------------- -------------- ---------------------- -------------- ---------------------- -------
  n (Boys/girls)         153/140        90/75                  63/65                                                                       
  TChol, mg/dL                                                                                                                             
   All                   158.2 (32.6)   155.0 (137.0--173.5)   157.0 (33.2)   151.0 (136.0--170.5)   159.8 (31.9)   157.5 (139.3--178.5)   0.277
   Boys                  158.7 (36.7)   155.0 (135.0--174.0)   157.2 (36.9)   150.0 (135.0--170.0)   160.9 (36.7)   158.0 (139.0--179.0)   0.379
   Girls                 157.7 (27.5)   154.5 (139.5--173.8)   156.8 (28.3)   154.0 (137.0--171.0)   158.7 (26.8)   155.0 (140.0--178.0)   0.547
   *P*                   0.734          0.692                  0.985                                                                       
  LDL-chol, mg/dL                                                                                                                          
   All                   89.3 (25.9)    87.0 (73.0--104.0)     87.3 (26.3)    84.0 (73.0--99.0)      91.9 (25.4)    92.0 (74.0--108.0)     0.050
   Boys                  87.3 (28.8)    83.0 (69.0--102.5)     85.1 (28.3)    82.0 (68.0--97.3)      90.3 (29.4)    87.0 (71.0--109.0)     0.220
   Girls                 91.5 (22.4)    89.0 (75.0--104.8)     89.9 (23.5)    87.0 (74.0--102.0)     93.4 (20.9)    92.0 (76.5--107.5)     0.156
   *P*                   0.073          0.176                  0.342                                                                       
  HDL-chol, mg/dL                                                                                                                          
   All                   44.2 (11.0)    43.0 (38.0--50.0)      44.5 (10.0)    44.0 (39.0--50.0)      43.9 (12.2)    43.0 (36.0--49.8)      0.267
   Boys                  44.0 (12.0)    43.0 (37.5--50.0)      44.3 (10.1)    44.0 (39.0--50.0)      43.5 (14.4)    43.0 (36.0--49.0)      0.252
   Girls                 44.5 (9.9)     44.0 (38.0--50.0)      44.7 (10.0)    44.0 (39.0--50.0)      44.2 (9.8)     42.0 (37.0--50.0)      0.700
   *P*                   0.728          0.891                  0.457                                                                       
  Non--HDL-chol, mg/dL                                                                                                                     
   All                   114.0 (32.5)   109.0 (92.5--130.0)    112.6 (32.4)   106.0 (91.0--128.0)    115.9 (32.7)   113.0 (94.3--134.0)    0.210
   Boys                  114.8 (37.1)   108.0 (89.0--130.0)    112.9 (36.5)   105.5 (89.0--129.3)    117.4 (38.2)   114.0 (89.0--134.0)    0.314
   Girls                 113.2 (26.7)   109.5 (95.0--129.8)    112.1 (26.9)   108.0 (98.0--127.0)    114.5 (26.5)   111.0 (95.0--134.5)    0.498
   *P*                   0.677          0.555                  0.930                                                                       
  TG, mg/dL                                                                                                                                
   All                   106.8 (50.7)   94.0 (73.0--126.0)     106.2 (52.3)   93.0 (70.0--128.0)     107.5 (48.8)   94.0 (77.3--121.8)     0.410
   Boys                  106.5 (54.8)   92.0 (70.5--126.0)     102.3 (55.0)   85.5 (66.8--121.3)     112.4 (54.4)   96.0 (79.0--128.0)     0.035
   Girls                 107.1 (46.1)   95.0 (74.0--126.5)     111.1 (48.8)   100.0 (72.0--137.0)    102.7 (42.6)   89.0 (74.5--120.5)     0.292
   *P*                   0.325          0.053                  0.270                                                                       

HDL-chol = high-density lipoprotein cholesterol; LDL-chol = low-density lipoprotein cholesterol; non--HDL-chol = non--high-density lipoprotein cholesterol; P~25~ = 25th percentile; P~75~ = 75th percentile; SD = standard deviation; TChol = total cholesterol; TG = triglycerides.

^\*^Significant differences between age groups or sex by the Mann-Whitney *U* test.

The overall prevalence of dyslipidaemia was 48.8%, with no differences between sexes. They have at least 1 abnormal lipid concentration, and low HDL-chol followed by high TG were the most common dyslipidaemias. The association of age, anthropometric variables (BMI and WHtR), and serum lipid and lipoprotein levels (TChol, LDL-chol, non--HDL-chol, HDL-chol, and TG) among adolescents with or without dyslipidaemia was also evaluated (Table [2](#T2){ref-type="table"}). No differences in age means were obtained. Boys with dyslipidaemia showed higher BMI and WHtR than their normolipidaemic counterparts, whereas no differences in anthropometric variables were found among girls. Boys with dyslipidaemia also showed lower values for HDL-chol levels and higher values for all other parameters than normolipidaemic participants.

###### 

Body composition and serum lipid levels with or without a diagnosis of dyslipidaemia^∗^

                         Boys           Girls                                                                                                                                              
  ---------------------- -------------- ---------------------- -------------- ---------------------- --------- -------------- ---------------------- -------------- ---------------------- ---------
  Age, yr                13.0 (1.7)     13.0 (11.3--14.0)      13.3 (1.7)     13.0 (12.0--15.0)      0.295     13.5 (1.8)     13.5 (12.0--15.0)      13.2 (1.9)     13.0 (11.0--15.0)      0.324
  BMI, kg/m^2^           20.4 (4.9)     19.5 (17.2--22.5)      22.5 (5.6)     21.9 (18.3--25.0)      0.006     21.5 (5.2)     20.8 (18.4--22.9)      23.1 (6.3)     22.2 (18.4--26.8)      0.125
  WHtR                   0.46 (0.08)    ---                    0.49 (0.08)    ---                    0.031     0.47 (0.08)    ---                    0.49 (0.08)    ---                    0.237
  TChol, mg/dL           145.9 (22.5)   147.0 (131.3--161.8)   172.8 (43.7)   166.0 (145.0--200.0)   \<0.001   153.7 (21.5)   153.0 (138.3--169.5)   161.6 (32.2)   156.0 (141.3--183.5)   0.208
  LDL-chol, mg/dL        80.5 (19.2)    78.5 (68.3--94.0)      94.7 (35.1)    93.0 (70.5--116.5)     0.007     87.2 (19.9)    87.5 (73.8--100.5)     95.8 (23.9)    91.5 (76.8--109.5)     0.058
  HDL-chol, mg/dL        49.2 (7.0)     48.0 (44.0--53.8)      38.3 (13.8)    36.0 (30.5--43.0)      \<0.001   50.3 (7.6)     49.0 (44.8--55.0)      38.6 (8.4)     38.0 (33.8--42.0)      \<0.001
  Non--HDL-chol, mg/dL   96.8 (21.0)    96.0 (85.0--109.5)     134.5 (40.9)   129.0 (109.0--154.0)   \<0.001   103.4 (20.6)   104.0 (86.5--118.0)    123.0 (28.6)   120.0 (102.8--139.0)   \<0.001
  TG, mg/dL              79.0 (21.6)    76.0 (85.0--109.5)     136.5 (63.8)   129.0 (109.0--154.0)   \<0.001   84.1 (21.3)    83.5 (68.0--95.3)      130.1 (52.4)   125.0 (94.0--153.0)    \<0.001

BMI = body mass index; CI = confidence interval; HDL-chol = high-density lipoprotein cholesterol; LDL-chol = low-density lipoprotein cholesterol; non--HDL-chol = non--high-density lipoprotein cholesterol; SD = standard deviation; TChol = total cholesterol; TG = triglycerides.

^\*^Significant differences between adolescents with and without dyslipidaemia by the Mann-Whitney *U* test.

The logistic regression analysis with anthropometric variables (Table [3](#T3){ref-type="table"}) showed that the risk of dyslipidaemia was associated with BMI status and abdominal obesity after adjustment for sex and age. Adolescents with high BMI were more likely to have at least 1 abnormal lipid level (overweight: odds ratio \[OR\]: 2.07; 95% confidence interval \[CI\]: 1.14--3.77, *P* *\<* 0.05; obesity: OR: 2.21, 95% CI: 1.11--4.41, *P* \< 0.05) than those with normal-weight. Abdominally obese subjects were also more likely to have at least 1 abnormal lipid level (OR: 2.30; 95% CI: 1.35--3.91, *P* *\<* 0.01) than their leaner counterparts. None of the other variables considered in the present study (age and sex) were significantly associated with dyslipidaemia.

###### 

Sociodemographic and lifestyle characteristics of adolescents with and without a diagnosis of dyslipidaemia^†^

                   Without dyslipidaemia (n = 150)   With dyslipidaemia (n = 143)               
  ---------------- --------------------------------- ------------------------------ ---- ------ -------------------------
  Age group, yr                                                                                 
   11--13          84                                50.9                           81   49.1   1.00 (ref.)
   14--16          66                                51.6                           62   48.4   0.97 (0.61--1.55)
  Sex                                                                                           
   Boys            80                                52.3                           73   47.7   1.00 (ref.)
   Girls           70                                50.0                           70   50.0   1.10 (0.69--1.73)
  BMI status                                                                                    
   Normal-weight   111                               57.5                           82   42.5   1.00 (ref.)
   Overweight      23                                39.7                           35   60.3   2.07 (1.14--3.77)^\*^
   Obesity         16                                38.1                           26   61.9   2.21 (1.11--4.41)^\*^
  WHtR groups                                                                                   
   \<0.5           102                               57.3                           76   42.7   1.00 (ref.)
   ≥0.5            31                                36.9                           53   63.1   2.30 (1.35--3.91)^\*\*^

BMI = body mass index; CI = confidence interval; OR = odds ratio; WHtR = waist-to-height ratio.

^\*^*P* \< 0.05; ^\*\*^*P* \< 0.01.

^†^Logistic regression analysis considering the effect of 1 explanatory variable.

Prevalence of risk categories for lipid serum and lipoprotein levels, and dyslipidaemia components among adolescents are shown in Supplemental Digital Content, Tables 1 and 2.

DISCUSSION
==========

The main finding of the present study is that half of the Nuevo León adolescents have at least 1 abnormal lipid concentration. Alterations in lipid profile have also been registered in more than half of the paediatric populations of Latin America ([@R18]--[@R20]). Despite differences in studied ages and the cut-off values for serum lipid level, which hampered direct comparison across studies, this prevalence of dyslipidaemia is higher than that in the previous studies in Brazil ([@R21]), Mexico City ([@R22]), and the United States ([@R23]).

According to previous studies conducted in Mexico City ([@R22],[@R24],[@R25]), low HDL-chol level followed by high TG levels were the most prevalent dyslipidaemias, and were related to BMI. In other countries, high TG levels were followed by low HDL-chol and high TChol levels ([@R20],[@R25]--[@R27]). High TChol prevalence was similar to previously reported data ([@R28],[@R29]), but higher than that in the previous studies ([@R22],[@R24]--[@R26],[@R30]). High LDL-chol levels were the least frequent dyslipidaemia and closely similar to previously reported data in Mexico City ([@R22],[@R24]), and in non--Latin American countries ([@R29],[@R31]), but higher ([@R25]) and lower ([@R27]) than that in Latin American and Asian countries, respectively.

Similar to Brazilian adolescents ([@R19]), there were no sex differences in lipid concentrations among Nuevo León adolescents. Several studies, however, found higher levels for TChol, LDL-chol, HDL-chol, and TG ([@R25],[@R26],[@R28],[@R32]--[@R34]), and lower prevalence of high LDL-chol levels ([@R34]), and low HDL-chol levels in girls than in boys ([@R25],[@R26],[@R28]). In Mexico City, low HDL-chol was more frequently found among boys than girls ([@R22],[@R24]), but women showed higher TChol, LDL-chol, and TG levels ([@R25],[@R26],[@R28],[@R32]--[@R35]) but lower ultimate CVD risk than men ([@R35],[@R36]).

Obesity is associated with increased rates of dyslipidaemia and other CVD risk factors ([@R37]). Higher values of TChol, LDL-chol, and TG ([@R22],[@R24],[@R38]), non--HDL-chol ([@R39]), and lower of HDL-chol ([@R22],[@R24]) have been found among overweight and/or obese adolescents than in normal-weight adolescents. In our study, adolescents with abdominal obesity were twice as likely to have at least 1 abnormal lipid level. Previously, WC has been positively associated with LDL-chol ([@R22]), TG ([@R19],[@R22],[@R40]), and non--HDL-c ([@R39]), and negatively associated with HDL-chol ([@R22],[@R40]). Waist-to-hip ratio has been also correlated to HDL-chol and TG ([@R40]) and WHtR correlated to TG and non--HDL-chol in adolescents ([@R19]). These findings agree with previous studies showing that WC is correlated with an abnormal lipid profile in teenagers ([@R22],[@R40]), and with a previous work which reported that WC is more closely associated with dyslipidaemia in children and adolescents than does BMI, which is more closely related to hypertension ([@R41]).

Dyslipidaemia is a modifiable CVD risk factor. The first step proposed to manage children and adolescents with elevated lipid levels is an intensive lifestyle modification, focused on normalizing body weight in patients with obesity, promoting a sensible diet, increasing levels of physical activity ([@R5],[@R6],[@R35]), and the active smoking prevention. Multiple studies have shown the efficacy of weight reduction in improving lipoprotein levels in paediatric obesity ([@R35]). The safety and effectiveness of the recommended diet for the general population is supported by large randomized trials. Increased physical activity has been associated with increased life expectancy and decreased risk of CVD ([@R42]). Therefore, lifestyle intervention is vital in managing a disease process that eventually carries high morbidity and mortality ([@R2]). Nevertheless, for individuals with familial hypercholesterolemia and high LDL-chol levels, healthy lifestyle behaviours are rarely enough to achieve lipid targets, and the expert panel set out specific steps for more intensive clinical management ([@R43]).

Strengths and Limitations
-------------------------

The main strength of the present study includes confirmation of the high dyslipidaemia prevalence among the Mexican population, making it necessary to develop effective preventive measures. Early intervention to encourage appropriate nutrition and physical activity at early ages could be relevant strategies to prevent and/or reduce the high risk for atherosclerosis in this population. This article also has limitations. First, the cross-sectional study design decreased the ability to show causality compared with longitudinal studies. The complex basis that, however, addresses the beginning of CVD risk in childhood, and the absence of long event-driven clinical trials, demands to consider any consistent evidence from observational studies ([@R43]). Second, data on the use of lipid-lowering medication are not available in EESN-NL 2011/2012 and therefore participants on lipid-lowering therapy were not excluded. Third, the guidelines do not account for variations in lipids due to race, sex, pubertal status ([@R35]), and geography ([@R5]), all of which are known to have a clinically relevant effect on lipoprotein values. Biological rhythms and seasonal variation in lipid profiles exist which should be particularly accounted for in cross-sectional analysis of relative risk, prevalence, or the rate of target achievement for lipid parameters ([@R44]). Finally, the differences in the ages studied and the cut-off values for serum lipid level could hamper the direct comparison across the different studies.

CONCLUSIONS
===========

Half of the Mexican adolescents living in the State of Nuevo León have at least 1 abnormal lipid concentration. A low HDL-chol level was the most common dyslipidaemia. BMI and abdominal obesity were associated with the prevalence of at least 1 abnormal lipid level.
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